LLY compared with XENE: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

XENEXenon Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

XENEXenon Pharmaceuticals Inc.

38.32▲+1.86%· post 38.49

ClosedNov 3 '26

Mkt cap$3.6BRevenue$8MQ1 FY25Revenue—

Compare

ClosedNov 3 '26

LLYELI Lilly & Co

XENEXenon Pharmaceuticals Inc.

1,407.25▼−0.27%post 1,416.42

Price

38.32▲+1.86%post 38.49

$1.3T

Mkt cap

$3.6B

Q3 FY26$24.4B

Revenue

$8MQ1 FY25

FY25$65.2B

Revenue

—

LLY1,407.25▼−0.27%vsXENE38.32▲+1.86%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

XENE: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

LLY, solidXENE, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only XENE 2

NBIXNeurocrine Biosciencessupplier

BHCBausch Healthsupplier

Role chip = supplier or customerSource: SEC EDGAR